Subscribe to RSS
DOI: 10.1055/s-2002-23565
Total Mesorectal Excision in Rectal Cancer Resection
Publication History
Publication Date:
03 April 2002 (online)
![](https://www.thieme-connect.de/media/ccrs/200201/lookinside/thumbnails/10.1055-s-2002-23565-1.jpg)
ABSTRACT
Despite the routine use of adjuvant chemoradiation for Stages II-III curatively resected rectal cancer, a significant percentage of patients ultimately fail locally and/or distally. Recognition of the importance of lateral, or circumferential, margins of resection has changed the surgeon's approach to oncologic resection of the rectum. The concept of total mesorectal excision (TME) is based upon the principle of resecting as an intact unit the rectum together with its lymphovascular drainage contained within the fascia propria. The widespread use of TME has been associated with a reduction in the incidence of local recurrence in large clinical series in the United States and Europe, thereby calling into question traditional indications for adjuvant therapy. Current efforts are directed at further defining the pattern of rectal cancer spread and identifying the subset of locally advanced rectal cancer patients that may be treated with a TME rectal cancer resection alone.
KEYWORD
Total mesorectal excision - rectal neoplasms - autonomic nerve preservation
REFERENCES
- 1 Ahmedin J, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin . 2002; 52 23-47
- 2 Tschmelitsch J, Kronberger P, Glaser K. Survival after surgical treatment of recurrent carcinoma of the rectum. J Am Coll Surg . 1994; 179 54-58
- 3 Grotz R L, Pemberton J H, Gunderson L L. Treatment results with radical surgery. In: Cohen A, Winawer SJ, Friedman MA, Gundersson LL, eds. Cancer of the Colon, Rectum, and Anus New York: McGraw-Hill 1995: 605-614
- 4 Phillips R K, Hittinger R, Blesovsky L. Local recurrence following `curative' surgery for large bowel cancer: II. The rectum and rectosigmoid. Br J Surg . 1984; 71 17-20
- 5 NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA . 1990; 264 1444-1450
- 6 O'Connell M J, Martenson J A, Wieand H S. Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med . 1994; 331 502-507
- 7 Krook J E, Moertel C G, Gunderson L L. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med . 1991; 324 709-715
- 8 Wexner S D, Jorge J M. Anatomy and embryology of the anus, rectum, and colon. In: Corman ML, ed. Colon and Rectal Surgery 4th ed. Philadelphia: Lippincott-Raven 1998: 1-26
- 9 Abulafi A M, Williams N S. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg . 1994; 81 7-19
- 10 Quirke P, Durdey P, Dixon M F, Williams N S. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet . 1986; 2 996-999
- 11 Ng I O, Luk I S, Yuen S T. Surgical lateral clearance in resected rectal carcinomas. A multivariate analysis of clinicopathologic features [comments]. Cancer . 1993; 71 1972-1976
- 12 de Haas-Kock F D, Baeten C G, Jager J J. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg . 1996; 83 781-785
- 13 Adam I J, Mohamdee M O, Martin I G. Role of circumferential margin involvement in the local recurrence of rectal cancer [comments]. Lancet . 1994; 344 707-711
- 14 Heald R J, Husband E M, Ryall R D. The mesorectum in rectal cancer surgery-the clue to pelvic recurrence?. Br J Surg . 1982; 69 613-616
- 15 Cawthorn S J, Parums D V, Gibbs N M. Extent of mesorectal spread and involvement of lateral resection margin as prognostic factors after surgery for rectal cancer [comments]. Lancet . 1990; 335 1055-1059
- 16 Hall N R, Finan P J, al-Jaberi T. Circumferential margin involvement after mesorectal excision of rectal cancer with curative intent. Predictor of survival but not local recurrence?. Dis Colon Rectum . 1998; 41 979-983
- 17 Carlsen E, Schlichting E, Guldvog I. Effect of the introduction of total mesorectal excision for the treatment of rectal cancer. Br J Surg . 1998; 85 526-529
- 18 MacFarlane J K, Ryall R D, Heald R J. Mesorectal excision for rectal cancer. Lancet . 1993; 341 457-460
- 19 Murty M, Enker W E, Martz J. Current status of total mesorectal excision and autonomic nerve preservation in rectal cancer. Semin Surg Oncol . 2000; 19 321-328
- 20 Heald R J, Moran B J, Ryall R D. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg . 1998; 133 894-899
- 21 Hida J, Yasutomi M, Maruyama T. Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision. J Am Coll Surg . 1997; 184 584-588
- 22 Reynolds J V, Joyce W P, Dolan J. Pathological evidence in support of total mesorectal excision in the management of rectal cancer. Br J Surg . 1996; 83 1112-1115
- 23 Scott N, Jackson P, al-Jaberi T. Total mesorectal excision and local recurrence: a study of tumour spread in the mesorectum distal to rectal cancer. Br J Surg . 1995; 82 1031-1033
- 24 Karanjia N D, Corder A P, Bearn P, Heald R J. Leakage from stapled low anastomosis after total mesorectal excision for carcinoma of the rectum. Br J Surg . 1994; 81 1224-1226
- 25 Bolognese A, Cardi M, Muttillo I A. Total mesorectal excision for surgical treatment of rectal cancer. J Surg Oncol . 2000; 74 21-73
- 26 Arbman G, Nilsson E, Hallbook O, Sjodahl R. Local recurrence following total mesorectal excision for rectal cancer [comments]. Br J Surg . 1996; 83 375-379
- 27 Enker W E, Thaler H T, Cranor M L, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg . 1995; 181 335-346
- 28 Enker W E, Merchant N, Cohen A M. Safety and efficacy of low anterior resection for rectal cancer: 681 consecutive cases from a specialty service. Ann Surg . 1999; 230 544-554
- 29 Law W I, Chu K W, Ho J W, Chan C W. Risk factors for anastomotic leakage after low anterior resection with total mesorectal excision. Am J Surg . 2000; 179 92-96
- 30 Merchant N B, Guillem J G, Paty P B. T3N0 rectal cancer: results following sharp mesorectal excision and no adjuvant therapy. J Gastrointest Surg . 1999; 3 642-647
- 31 Zaheer S, Pemberton J H, Farouk R. Surgical treatment of adenocarcinoma of the rectum. Ann Surg . 1998; 227 800-811
- 32 Havenga K, Enker W E, Norstein J. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol . 1999; 25 368-374
- 33 Arenas R B, Fichera A, Mhoon D, Michelassi F. Total mesenteric excision in the surgical treatment of rectal cancer: a prospective study. Arch Surg . 1998; 133 608-612
- 34 Kockerling F, Reymond M A, Altendorf-Hofmann A. Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol . 1998; 16 324-329
- 35 Martling A L, Holm T, Rutqvist L E. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet . 2000; 356 93-96
- 36 Bokey E L, Ojerskog B, Chapuis P H. Local recurrence after curative excision of the rectum for cancer without adjuvant therapy: role of total anatomical dissection. Br J Surg . 1999; 86 1164-1170
- 37 Lopez-Kostner F, Lavery I C, Hool G R. Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery . 1998; 124 612-661
- 38 Willett C G, Badizadegan K, Ancukiewicz M, Shellito P C. Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy?. Dis Colon Rectum . 1999; 42 167-173
- 39 Kapiteijn E, Marijnen C A, Nagtegaal I D. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med . 2001; 345 638-646
- 40 Wolmark N, Wieand H S, Hyams D M. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst . 2000; 92 388-396
- 41 Bissett I P, Fernando C C, Hough D M. Identification of the fascia propria by magnetic resonance imaging and its relevance to preoperative assessment of rectal cancer. Dis Colon Rectum . 2001; 44 259-265
- 42 Brown G, Richards C J, Newcombe R G. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology . 1999; 211 215-222
- 43 Beets-Tan R G, Beets G L, Vliegen R F. Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet . 2001; 357 497-504
- 44 Blomqvist L, Rubio C, Holm T. Rectal adenocarcinoma: assessment of tumour involvement of the lateral resection margin by MRI of resected specimen. Br J Radiol . 1999; 72 18-23
- 45 Grabbe E, Lierse W, Winkler R. The perirectal fascia: morphology and use in staging of rectal carcinoma. Radiology . 1983; 149 241-246
- 46 Nishioka T, Shimizu T, Shirato H. Relation between preoperative CT findings in rectal cancer and local recurrence rate. A pilot study. Acta Oncol . 1993; 32 555-558
- 47 Milsom J W, Bohm B, Hammerhofer K A. A prospective, randomized trial comparing laparoscopic versus conventional techniques in colorectal cancer surgery: a preliminary report [comments]. J Am Coll Surg . 1998; 187 46-55
- 48 Hartley J E, Mehigan B J, Qureshi A E. Total mesorectal excision: assessment of the laparoscopic approach. Dis Colon Rectum . 2001; 44 315-321
- 49 Weiser M R, Milsom J W. Laparoscopic total mesorectal excision with autonomic nerve preservation. Semin Surg Oncol . 2000; 19 396-403
- 50 Guillem J G, Puig-La Calle Jr J, Akhurst T. Prospective assessment of primary rectal cancer response to preoperative radiation and chemotherapy using 18-fluorodeoxyglucose positron emission tomography. Dis Colon Rectum . 2000; 43 18-24